BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34339032)

  • 1. PAX8, an Emerging Player in Ovarian Cancer.
    Gokulnath P; Soriano AA; de Cristofaro T; Di Palma T; Zannini M
    Adv Exp Med Biol; 2021; 1330():95-112. PubMed ID: 34339032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 3. Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium.
    Rodgers LH; Ó hAinmhire E; Young AN; Burdette JE
    Oncotarget; 2016 May; 7(22):32785-95. PubMed ID: 27129161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma.
    de Cristofaro T; Di Palma T; Soriano AA; Monticelli A; Affinito O; Cocozza S; Zannini M
    Oncotarget; 2016 Jul; 7(27):41929-41947. PubMed ID: 27259239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma.
    Ghannam-Shahbari D; Jacob E; Kakun RR; Wasserman T; Korsensky L; Sternfeld O; Kagan J; Bublik DR; Aviel-Ronen S; Levanon K; Sabo E; Larisch S; Oren M; Hershkovitz D; Perets R
    Oncogene; 2018 Apr; 37(17):2213-2224. PubMed ID: 29379162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Origin of ovarian epithelial inclusions and its relationship with the development of low-grade serous carcinoma].
    Xiang L; Li J; Wang LJ; Zheng WX; Kong BH
    Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):729-35. PubMed ID: 22321344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis reveals a role for PAX8 in peritoneal colonization of high grade serous ovarian cancer that can be targeted with micelle encapsulated thiostrepton.
    Hardy LR; Pergande MR; Esparza K; Heath KN; Önyüksel H; Cologna SM; Burdette JE
    Oncogene; 2019 Aug; 38(32):6003-6016. PubMed ID: 31296958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development.
    Sherman-Baust CA; Kuhn E; Valle BL; Shih IeM; Kurman RJ; Wang TL; Amano T; Ko MS; Miyoshi I; Araki Y; Lehrmann E; Zhang Y; Becker KG; Morin PJ
    J Pathol; 2014 Jul; 233(3):228-37. PubMed ID: 24652535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAX8 modulates the tumor microenvironment of high grade serous ovarian cancer through changes in the secretome.
    Salvi A; Hardy LR; Heath KN; Watry S; Pergande MR; Cologna SM; Burdette JE
    Neoplasia; 2023 Feb; 36():100866. PubMed ID: 36586182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular markers derived from ovarian cancer and its correlation with the types of oviductal epithelial lesions].
    Yuan Y; Zhu W; Gong G; Jiang J; Wang Y; Wu X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 May; 44(5):528-534. PubMed ID: 31303616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UnPAXing the Divergent Roles of PAX2 and PAX8 in High-Grade Serous Ovarian Cancer.
    Hardy LR; Salvi A; Burdette JE
    Cancers (Basel); 2018 Aug; 10(8):. PubMed ID: 30096791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcription factor PAX8 promotes angiogenesis in ovarian cancer through interaction with SOX17.
    Chaves-Moreira D; Mitchell MA; Arruza C; Rawat P; Sidoli S; Nameki R; Reddy J; Corona RI; Afeyan LK; Klein IA; Ma S; Winterhoff B; Konecny GE; Garcia BA; Brady DC; Lawrenson K; Morin PJ; Drapkin R
    Sci Signal; 2022 Apr; 15(728):eabm2496. PubMed ID: 35380877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAX8 expression in ovarian surface epithelial cells.
    Adler E; Mhawech-Fauceglia P; Gayther SA; Lawrenson K
    Hum Pathol; 2015 Jul; 46(7):948-56. PubMed ID: 26079312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of paired box genes 8 and 2 expression in epithelium tissues and the related tumors].
    Song Y; Huang X; Shen GH; Liu XY; Zhang X
    Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):424-428. PubMed ID: 28635231
    [No Abstract]   [Full Text] [Related]  

  • 15. Emerging roles for PAX8 in ovarian cancer and endosalpingeal development.
    Bowen NJ; Logani S; Dickerson EB; Kapa LB; Akhtar M; Benigno BB; McDonald JF
    Gynecol Oncol; 2007 Feb; 104(2):331-7. PubMed ID: 17064757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of WT1 and PAX8 in the epithelial tumours of Malaysian women with ovarian cancer.
    Rhodes A; Vallikkannu N; Jayalakshmi P
    Br J Biomed Sci; 2017 Apr; 74(2):65-70. PubMed ID: 28367736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiles of ovarian low-grade serous carcinoma resemble those of fallopian tube epithelium.
    Qiu C; Lu N; Wang X; Zhang Q; Yuan C; Yan S; Dongol S; Li Y; Sun X; Sun C; Zhang Z; Zheng W; Kong B
    Gynecol Oncol; 2017 Dec; 147(3):634-641. PubMed ID: 28965696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pax8: a marker for carcinoma of Müllerian origin in serous effusions.
    Tong GX; Devaraj K; Hamele-Bena D; Yu WM; Turk A; Chen X; Wright JD; Greenebaum E
    Diagn Cytopathol; 2011 Aug; 39(8):567-74. PubMed ID: 20607683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift.
    Reade CJ; McVey RM; Tone AA; Finlayson SJ; McAlpine JN; Fung-Kee-Fung M; Ferguson SE
    J Obstet Gynaecol Can; 2014 Feb; 36(2):133-140. PubMed ID: 24518912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA Methylome Analyses Implicate Fallopian Tube Epithelia as the Origin for High-Grade Serous Ovarian Cancer.
    Klinkebiel D; Zhang W; Akers SN; Odunsi K; Karpf AR
    Mol Cancer Res; 2016 Sep; 14(9):787-94. PubMed ID: 27259716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.